Howard Schub
Neurology with Special Qualifications in Child Neurology · Atlanta, GANPI 1386719185
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.7%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 31.9% of the total. Reporting peaked in 2019 at $5,287 and has fallen 99.3% since, to $39 in 2025.
Across 189 payments — averaging $39.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$2K
- Supernus Pharmaceuticals, Inc.$2K
- Greenwich Biosciences, Inc.$781
- UCB, Inc.$360
- Eisai Inc.$321
- Sunovion Pharmaceuticals Inc.$318
- plus $1K from 16 others
What the payments were for
- Consulting fees$1,12015%
- Speaking & faculty fees$1,98026%
- Food & beverage$4,39759%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 13 | $2,394 |
| Supernus Pharmaceuticals, Inc. | 36 | $1,933 |
| Greenwich Biosciences, Inc. | 22 | $781 |
| UCB, Inc. | 13 | $360 |
| Eisai Inc. | 19 | $321 |
| Sunovion Pharmaceuticals Inc. | 15 | $318 |
| Upsher-smith Laboratories LLC | 10 | $278 |
| Tris Pharma Inc | 8 | $172 |
| Neos Therapeutics, LP | 8 | $136 |
| Aquestive Therapeutics, Inc. | 6 | $120 |
| Mallinckrodt Enterprises LLC | 5 | $116 |
| Corium, LLC | 7 | $105 |
| Aprecia Pharmaceuticals, LLC | 4 | $89 |
| Shire North American Group Inc | 4 | $72 |
| SK Life Science, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Adlon Therapeutics L.p. | 3 | $48 |
| Vertical Pharmaceuticals, LLC | 3 | $39 |
| Zogenix Inc. | 2 | $33 |
| Livanova USA, Inc. | 2 | $31 |
| Biomarin Pharmaceutical Inc. | 2 | $24 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$2,220
- OXTELLAR XR$613
- QELBREE$225
- Epidiolex$118
How this compares
$7,497 in reported general payments places this provider in the 70th percentile of 41 neurology with special qualifications in child neurology providers in Georgia.
See all neurology with special qualifications in child neurology providers in Georgia →
Other neurology with special qualifications in child neurology in Atlanta
- Chaouki KhouryAtlanta$978K
- Han PhanAtlanta$44K
- Raymond ChengAtlanta$40K
- Sonam BhallaAtlanta$23K
- Cherise FrazierAtlanta$9K
- Ton de GrauwAtlanta$4K
- Jamika Hallman-CooperAtlanta$2K
- Moira BlackAtlanta$1K
- Jenny LinAtlanta$1K
- Kishore VedalaAtlanta$733
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.